News & Updates

In the treatment of patients with SAPHO syndrome, the use of upadacitinib appears to confer rapid improvements in musculoskeletal and cutaneous lesions, without serious adverse reactions, according to a retrospective observational study.

Treatment with the oral JAK inhibitor upadacitinib appears to lead to substantial hair regrowth in patients with severe alopecia areata, as shown in the two parallel phase III UP-AA1 and UP-AA2 studies.

Short-term exposure to ambient fine particulate matter (PM2.5) appears to increase the risk of cardiovascular mortality, suggests a study.

Adherence to Mediterranean lifestyle, social participation, physical activity, sleep, and sociodemographic and health-related factors all contribute to life satisfaction and psychological distress, suggests a study.

Assessment of high-sensitivity cardiac troponin I (hs-cTnI) trajectories during the immediate peripartum period hint at delivery as a physiologic cardiovascular “stress test,” according to a study.

Prenatal exposure to antiseizure medications is associated with increased risk of poor foetal growth, according to a large prospective study.

For adult patients with type 2 diabetes who are recovering from dialysis-requiring acute kidney injury (AKI-D), initiating sodium-glucose cotransporter-2 (SGLT-2) inhibitor therapy within 30 days of discharge is associated with fewer adverse kidney events compared with later initiation, as shown in a retrospective study.

Early discharge of very preterm infants with home nasogastric tube (NGT) feeding does not appear to increase psychological distress among parents both at discharge and at 3 months corrected age (CA), suggests a study.

Immediate ambulatory electrocardiographic (ECG) monitoring initiated among patients with syncope in the emergency department (ED) falls short of preventing recurrent syncope over 1 year, according to the ASPIRED study presented at ESC Congress 2026.